| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/31/2010 | US7786283 BRI constructs and methods of using |
| 08/31/2010 | US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 08/31/2010 | US7786279 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 08/31/2010 | US7786278 improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer; carcinoembryonic antigen (CEA) |
| 08/31/2010 | US7786276 Extraction of glycoprotein from a polar solution; obtain a polar solvent, mix with nonpolar solvent, form glycoprotein interface layer, recover glycoprotein, replace solution; to filter or sequester glycoproteins and their carbohydrate moieties using glycoprotein membranes |
| 08/31/2010 | US7786275 Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells |
| 08/31/2010 | US7786272 bind to biomarker overexpressed in colon or lung tumor cells |
| 08/31/2010 | US7786271 Antibodies that inhibit TSLP activity |
| 08/31/2010 | US7786269 The antibodies or fragments specifically bind to an extracellular epitope of an Epstein Barr Virus latent membrane protein; anticarcinogenic agents; cancer vaccines |
| 08/31/2010 | US7786265 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass |
| 08/31/2010 | US7786264 Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof |
| 08/31/2010 | US7786263 Human T1R2 taste receptor polypeptides |
| 08/31/2010 | US7786262 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases |
| 08/31/2010 | US7786261 protein of an ectodomain of a transforming growth factor beta membrane-bound receptor and a peptide subunit of an alpha -helical coiled-coil; selecting compounds capable of inhibiting ligand binding and kinase activity |
| 08/31/2010 | US7786260 immunogenic; treating or preventing Helicobacter infection in a mammalian host; gastroduodenal disease |
| 08/31/2010 | US7786258 Methods for inhibiting immune complex formation in a subject |
| 08/31/2010 | US7786257 Lymphocyte receptors peptide for use as tool in prevention and treatment of infection, autoimmune and cell proliferative disorders; mimetics |
| 08/31/2010 | US7786256 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins |
| 08/31/2010 | US7786255 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 08/31/2010 | US7786103 Method for isolating an intestinal cholesterol binding protein |
| 08/31/2010 | US7786086 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody |
| 08/31/2010 | US7786082 Combinations of human proteins to enhance in vivo viability of stem cells and progenitor cells |
| 08/31/2010 | US7786081 Peptide composition |
| 08/31/2010 | US7786080 wild type protein; leucine in the wild type protein at the amino acid position 51 of human BMP-2 is substituted by proline in the mutein; biodrugs for treating fibrotic diseases, wound healing, hypervascularization, vascular diseases, fractures, and osteoporosis |
| 08/31/2010 | US7786074 Composition and methods for promoting wound healing and tissue regeneration |
| 08/31/2010 | US7786072 Stabilized compounds having secondary structure motifs |
| 08/31/2010 | US7785887 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes |
| 08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
| 08/31/2010 | US7785885 Rescue of plant cell cultures and suspensions after cryopreservation-induced damage |
| 08/31/2010 | US7785881 MAGE-C2 antigenic peptides and uses thereof |
| 08/31/2010 | US7785879 Pregnane X receptor compositions, crystals and uses thereof |
| 08/31/2010 | US7785873 Antigen arrays for treatment of bone disease |
| 08/31/2010 | US7785859 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/31/2010 | US7785849 Cyclic nucleotide-specific phosphodiesterases from Leishmania and uses thereof |
| 08/31/2010 | US7785845 culturing a microorganism with enhanced or overexpressed L-glutamic acid-export gene; efficiency |
| 08/31/2010 | US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use |
| 08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 08/31/2010 | US7785833 Methods and means for producing proteins with predetermined post-translational modifications |
| 08/31/2010 | US7785830 comprising a polynucleotide encoding a fusion protein that has the signal sequence of the gac gene of Pseudomonas diminuta and a polypeptide of interest, a prokaryotic host cell transformed with such an expression vector and a process for production of a polypeptide of interest using the vector |
| 08/31/2010 | US7785829 polynucleotide encoding a soluble polypeptide; for decreasing inhibition of axonal growth of a central nervous system neuron; neurological diseases, disorders and injuries such as spinal cord injury |
| 08/31/2010 | US7785828 Production of antimicrobial proteins in fusion proteins |
| 08/31/2010 | US7785827 allows and facilitates production and accumulation of tRNAs that are misaminoacylated with nonstandard and noncognate amino acids; can be used to introduce novel amino acids into proteins |
| 08/31/2010 | US7785824 Hydrolysed casein product comprising tripeptides IPP and/or VPP |
| 08/31/2010 | US7785812 Chemotherapy potentiation; drug discovery and design |
| 08/31/2010 | US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders |
| 08/31/2010 | US7785809 Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof |
| 08/31/2010 | US7785807 Voltage-gated, pH-sensitive anion channel and its novel splice variant involved in taste sensation |
| 08/31/2010 | US7785804 Mammalian CX3C chemokine antibodies |
| 08/31/2010 | US7785803 Antibody diagnostic kits and methods of use |
| 08/31/2010 | US7785802 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 08/31/2010 | US7785801 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 08/31/2010 | US7785794 Variant TLR4 nucleic acid and uses thereof |
| 08/31/2010 | US7785792 screening for compounds that modulate the activity of chromatin modifying enzymes, comprising contacting the compound with a cell comprising a polynucleotide encoding fusion proteins comprising zinc finger proteins and chromatin modifying enzymes anddetermining the difference in gene expression |
| 08/31/2010 | US7785789 diagnosis autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in humans comprising detecting homozygosity or heterozygosity of a C to T nonsense mutation and an A to G missense mutation of a DNA sequence; cleavage with Taq 1 or another enzyme which cleaves recognition site 5'-TCGA-3' |
| 08/31/2010 | US7785779 Generating vector comprising regulatory sequences associated with protein translation elongation factor TU (P EF-TU); improving exogenous gene expression |
| 08/31/2010 | US7785777 conducting a bioassay on a DNA sample or an RNA sample, to determine the presence or absence of gene mutations associated with a genetic disorder with clinical features including exocrine pancreatic insufficiency, haematological dysfunction and skeletal abnormalities |
| 08/31/2010 | US7785617 Usable both as a scaffold for the growth of new tissue and as a delivery system or implant for pharmaceuticals, vaccines, hormones enzymes, and nutrients; high strength bonding between cell-compatible crosslinkers, e.g., biotin and/or avidin, and polymer, e.g., polyglycolic acid; diffusion; shaping |
| 08/31/2010 | US7785608 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/31/2010 | US7785607 rapid immune assay based on evaluation of frequency of Interferon (IFN) gamma-producing antigen-specific T lymphocytes responding to selected peptide sequences from Mycobacterium tuberculosis, selected for their immunogenicity; discriminates between latent tuberculosis infection or active infection |
| 08/31/2010 | US7785606 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof |
| 08/31/2010 | US7785604 nine residue peptides (ApoptoM) from flavivirus M ectodomain able to modulate specifically the apoptotic activity of diverse flavivirus; use for the treatment and/or the prevention of flavivirus-linked infections and cancers |
| 08/31/2010 | US7785602 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 08/31/2010 | US7785601 administering a hematopoietic growth factor such as granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor to a mammal |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/31/2010 | US7785598 Alternate reading frame hepatitis C virus peptides and uses thereof |
| 08/31/2010 | US7785597 generating an immune response, comprising administering to a mammal variable major protein (VMP)-like polypeptides as antigens for immunoprophylaxis, immunotherapy and immunodiagnosis; antibodies; Lyme disease |
| 08/31/2010 | US7785593 Antibody (11C7) anti nogo a and its pharmaceutical use |
| 08/31/2010 | US7785589 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans |
| 08/31/2010 | US7785588 Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors |
| 08/31/2010 | US7785586 Capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two or more, mutated forms of the HBsAg antigen |
| 08/31/2010 | US7785580 comprising a polypeptide coupled to a non-protein polymer selected from polyethylene glycol or polypropylene glycol, used for the treatment of respiratory system disorders such as asthma; increased plasma half-life |
| 08/31/2010 | US7785579 enhancing the tumoricidal activity of an isolated TNF protein comprising bonding to the TNF to polyethyleneglycol; increased circulating half-life of the TNF while not increasing its toxicity; antitumor or anticarcinogenic agents with reduced side effects |
| 08/31/2010 | US7785577 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 08/31/2010 | CA2480427C Novel potassium-dependent sodium-calcium exchanger |
| 08/31/2010 | CA2336472C Negative-sense rna virus vector for nerve cell |
| 08/31/2010 | CA2332817C Il-6 antagonist peptides |
| 08/31/2010 | CA2290886C Nucleic acid binding proteins |
| 08/31/2010 | CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes |
| 08/31/2010 | CA2217871C Altered polypeptides with increased half-life |
| 08/31/2010 | CA2190371C Receptor for oncostatin m |
| 08/26/2010 | WO2010096838A2 Proproteins and methods of use thereof |
| 08/26/2010 | WO2010096693A2 Methods and materials for generating t cells |
| 08/26/2010 | WO2010096681A2 Modifications of cupredoxin derived peptides and methods of use thereof |
| 08/26/2010 | WO2010096588A2 Cell culture media containing combinations of proteins |
| 08/26/2010 | WO2010096561A1 Synthetic hiv/siv gag proteins and uses thereof |
| 08/26/2010 | WO2010096385A2 Methods and compositions for the treatment of autoimmune disease |
| 08/26/2010 | WO2010095966A1 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector |
| 08/26/2010 | WO2010095910A2 Polypeptide having function for delaying anthesis or suppressing growth, polynucleotide encoding the same, and use thereof |
| 08/26/2010 | WO2010095881A2 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof |
| 08/26/2010 | WO2010095455A1 Hypo-immunogenic streptavidin and use thereof |
| 08/26/2010 | WO2010095428A1 Foxm1 peptides and vaccines containing the same |
| 08/26/2010 | WO2010095150A2 Nucleic acids of jatropha curcas and its applications |
| 08/26/2010 | WO2010095138A1 Novel kinase-start gene conferring resistance to plant disease and transgenic plants comprising it |
| 08/26/2010 | WO2010094906A1 The stabilisation of proteins |
| 08/26/2010 | WO2010094901A1 Means for purifying a protein of blood plasma and methods for implementing same |
| 08/26/2010 | WO2010094900A1 Means for purifying a coagulation protein, and methods for implementing same |
| 08/26/2010 | WO2010094699A1 Attenuated salmonella enteritidis strain |
| 08/26/2010 | WO2010094663A1 Inactivated dengue virus vaccine with aluminium-free adjuvant |
| 08/26/2010 | WO2010094587A1 Microbial siderophore synthesis |
| 08/26/2010 | WO2010094499A1 Methods and compositions for diagnosis and treatment of cancer |